In Q3'26, Oracle's total operating expenses reached $5.05B USD, comprising $2.61B in R&D expenses and $2.44B in SG&A expenses, reflecting a modest quarterly increase driven primarily by R&D investments. Over the period from Q4'23 to Q3'26, R&D expenses exhibited steady growth from $2.23B to $2.61B, with notable acceleration in FY25 (peaking at $2.65B in Q4'25) before stabilizing in FY26, indicating sustained focus on innovation. In contrast, SG&A expenses fluctuated between $2.39B and $2.77B, showing an overall upward trend from $2.69B but with volatility, including a dip to $2.39B in Q1'25 and Q1'26, suggesting variable administrative and sales costs amid business expansion. The stacked bar chart highlights R&D's increasing share of total expenses, rising from about 45% to 52%, underscoring Oracle's strategic emphasis on research amid rising operational demands.